Feb 01, 2019 - GlaxoSmithKline (GSK) closed at $39.20 in the latest trading session, marking no change from the prior day.
Jan 30, 2019 -
Jan 29, 2019 - Pharmaceutical giant Pfizer braced investors for little-to-no revenue growth in 2019 after its blockbuster erectile dysfunction drug Viagra and others lost patent protection and pain killer Lyrica faces similar competition from generic drugmakers.
Jan 28, 2019 - Fisher’s 13F portfolio value decreased from $82.37B to $73.22B in Q4 2018.Visa Inc., Amazon.com, Apple Inc., Microsoft, and Pfizer are the largest five individual stock positions.Fisher has substantia
Jan 16, 2019 -
Jan 14, 2019 - Dynavax recently presented a company outlook for 2019 at the JP Morgan Healthcare Conference. During the presentation, CEO Eddie Gray revealed encouraging HEPISLAV-B sales for Q4 of ~$3.7M.2018 was a
Jan 14, 2019 - Following precipitous revenue losses attributable to its portfolio of HCV medicines, Gilead finds itself in improving financial straits.2019 will see the release of pivotal data from Phase III clinica
Jan 11, 2019 - Lilly (LLY) is spending $8 billion to buy small cancer biotech Loxo Oncology. Big Pharma CEOs hint at spur in M&A activity in 2019.
Jan 11, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Jan 11, 2019 - Here we present four therapeutic areas whose pipeline developments are expected to garner a lot of interest in 2019.